197 related articles for article (PubMed ID: 18427761)
21. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy.
Fung MC; Storniolo AM; Nguyen B; Arning M; Brookfield W; Vigil J
Cancer; 1999 May; 85(9):2023-32. PubMed ID: 10223245
[TBL] [Abstract][Full Text] [Related]
22. [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature].
Dilhuydy MS; Delclaux C; Pariente A; De Precigout V; Aparicio M
Rev Med Interne; 2002 Feb; 23(2):189-92. PubMed ID: 11876063
[TBL] [Abstract][Full Text] [Related]
23. [Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?].
Graas MP; Houbiers G; Demolin G; Stultiens A; Focan C
Rev Med Liege; 2012 Dec; 67(12):644-8. PubMed ID: 23342875
[TBL] [Abstract][Full Text] [Related]
24. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
Masset C; Dubois B; Rorive G
Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
Boctor FN
Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
[TBL] [Abstract][Full Text] [Related]
26. Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.
Glezerman I; Kris MG; Miller V; Seshan S; Flombaum CD
Clin Nephrol; 2009 Feb; 71(2):130-9. PubMed ID: 19203505
[TBL] [Abstract][Full Text] [Related]
27. Gemcitabine-induced hemolytic uremic syndrome: a case report.
Brodowicz T; Breiteneder S; Wiltschke C; Zielinski CC
J Natl Cancer Inst; 1997 Dec; 89(24):1895-6. PubMed ID: 9414181
[No Abstract] [Full Text] [Related]
28. [Hemolytic uremic syndrome following gemcitabine treatment].
Bourquin V; Guinand A; Haenni C; Giovannini M; Delouche D; Dettwiler S; Moll S
Rev Med Suisse; 2008 Apr; 4(154):1056-61. PubMed ID: 18557535
[TBL] [Abstract][Full Text] [Related]
29. [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].
Wato M; Inaba T; Ishikawa H; Ishikawa S; Baba N; Miyoshi M; Senoh T; Nagano T; Takaguchi K; Watanabe S; Kawai K
Nihon Shokakibyo Gakkai Zasshi; 2010 Oct; 107(10):1676-85. PubMed ID: 20938119
[TBL] [Abstract][Full Text] [Related]
30. Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura.
Volcy J; Nzerue CM; Oderinde A; Hewan-Iowe K
Am J Kidney Dis; 2000 Jan; 35(1):E3. PubMed ID: 10620564
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine-associated hemolytic-uremic syndrome.
Walter RB; Joerger M; Pestalozzi BC
Am J Kidney Dis; 2002 Oct; 40(4):E16. PubMed ID: 12324937
[TBL] [Abstract][Full Text] [Related]
32. [Gemcitabine-induced thrombotic microangiopathy].
Teixeira L; Debourdeau P; Zammit C; Estival JL; Pavic M; Colle B
Presse Med; 2002 Apr; 31(16):740-2. PubMed ID: 12148351
[TBL] [Abstract][Full Text] [Related]
33. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E
Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557
[TBL] [Abstract][Full Text] [Related]
34. Gemcitabine-induced hemolytic uremic syndrome mimicking scleroderma renal crisis presenting with Raynaud's phenomenon, positive antinuclear antibodies and hypertensive emergency.
Yamada Y; Suzuki K; Nobata H; Kawai H; Wakamatsu R; Miura N; Banno S; Imai H
Intern Med; 2014; 53(5):445-8. PubMed ID: 24583433
[TBL] [Abstract][Full Text] [Related]
35. Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).
Assi C; Lepage C; Jouve JL; Sgro C; Bedenne L
Gastroenterol Clin Biol; 2010 Nov; 34(11):640-2. PubMed ID: 21051168
[No Abstract] [Full Text] [Related]
36. Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.
Bharthuar A; Egloff L; Becker J; George M; Lohr JW; Deeb G; Iyer RV
Cancer Chemother Pharmacol; 2009 Jun; 64(1):177-81. PubMed ID: 19116715
[TBL] [Abstract][Full Text] [Related]
37. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
38. Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy.
Hochstetler LA; Flanigan MJ; Lager DJ
Am J Kidney Dis; 1994 Mar; 23(3):444-50. PubMed ID: 8128949
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced thrombotic microangiopathy.
Zakarija A; Bennett C
Semin Thromb Hemost; 2005 Dec; 31(6):681-90. PubMed ID: 16388419
[TBL] [Abstract][Full Text] [Related]
40. Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.
Facchini L; Lucchesi M; Stival A; Roperto RM; Melosi F; Materassi M; Farina S; Tintori V; de Martino M; Sardi I
J Med Case Rep; 2017 Jul; 11(1):209. PubMed ID: 28747219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
